$KRSA 3 SEC Filings

Filed On	Filing
10 Sep 2026	Form 3: Violin Jonathan, Director Holds 207,400 shares of Common Stock
10 Sep 2026	Form 3: Leoni Matthew James, Chief Medical Officer
10 Sep 2026	Form 3: Pernice Michelle Patricia, Director
10 Sep 2026	Form 3: Henson Heidi, Director
10 Sep 2026	Form 3: Gottesdiener Andrew, Director No securities owned
10 Sep 2026	Form 3: Fairmount Funds Management Llc, Director and 4 others Holds 6,911,174 shares of Common Stock
10 Sep 2026	Form 3: Shah Nimish P, Director Holds 4,549,585 shares of Common Stock
10 Sep 2026	Form 3: Vignola Mark J., Chief Financial Officer
11 Mar 2024	Form 3: Chicko Rhonda M., Chief Financial Officer Holds 18 shares of Common Stock
11 Dec 2023	Form 3: Katabi Dina, Director Holds 20,000 shares of Common Stock
07 Dec 2023	Form 3: Higgins Michael J, Director Holds 21,650 shares of Common Stock
04 Dec 2023	Form 3: Graul Regina Margaret, President Holds 50,000 shares of Common Stock
26 Jul 2022	Form 3: Hyman Steven, Director Holds 0 shares of Common Stock
19 May 2021	Form 3: Desouza Errol B, Director Holds 0 shares of Common Stock
11 Jan 2021	Form 3: Gjino Anjeza, Chief Financial Officer Holds 15,224 shares of Common Stock
11 Jan 2021	Form 3: Gault Cheryl, Chief Operating Officer Holds 8,500 shares of Common Stock
30 Dec 2020	Form 3: Wright Christopher I, Chief Medical Officer Holds 17,009 shares of Common Stock
10 Aug 2020	Form 3: Slate Path Capital Lp, 10% owner and 1 other Holds 6,196,063 shares of Common Stock, no par value
01 May 2019	Form 3: Busch Andreas, Chief Innovation Officer No securities owned
03 Apr 2019	Form 3: Hecht Peter M, Director No securities owned

Comments